نتائج البحث - "Wasiu A, Olowu"

المصدر: Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group & Rossing, P 2020, ' KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease ', Kidney International, vol. 98, no. 4S, pp. S1-S115 . https://doi.org/10.1016/j.kint.2020.06.019

مصطلحات موضوعية: Clinical Practice, medicine.medical_specialty, Nephrology, business.industry, Diabetes management, Medicine, Guideline, business, medicine.disease, Intensive care medicine, Kidney disease

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2f170d4f5575c2b982ed622a5f0f719
https://doi.org/10.1016/j.kint.2020.06.019

6

Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline

المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Groningen Kidney Center (GKC)

المصدر: Kidney International, 98(4), 839-848. ELSEVIER SCIENCE INC
de Boer, I H, Caramori, M L, Chan, J C N, Heerspink, H J L, Hurst, C, Khunti, K, Liew, A, Michos, E D, Navaneethan, S D, Olowu, W A, Sadusky, T, Tandon, N, Tuttle, K R, Wanner, C, Wilkens, K G, Zoungas, S, Lytvyn, L, Craig, J C, Tunnicliffe, D J, Howell, M, Tonelli, M, Cheung, M, Earley, A & Rossing, P 2020, ' Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline : evidence-based advances in monitoring and treatment ', Kidney International, vol. 98, no. 4, pp. 839-848 . https://doi.org/10.1016/j.kint.2020.06.024

مصطلحات موضوعية: 0301 basic medicine, self-management, 030232 urology & nephrology, renin-angiotensin system, law.invention, 0302 clinical medicine, team-based care, Randomized controlled trial, systematic review, law, GLUCOSE CONTROL, KDIGO, COMPLICATIONS, Self-management, hemodialysis, SGLT2 inhibitor, models of care, angiotensin II receptor blocker, nutrition, Nephrology, guideline, medicine.medical_specialty, lifestyle, Evidence-based practice, HbA1c, GLP-1 receptor agonist, METFORMIN, glycemic targets, CARDIOVASCULAR OUTCOMES, 03 medical and health sciences, Diabetes management, evidence-based, Diabetes mellitus, medicine, Intensive care medicine, Glycemic, business.industry, MORTALITY, KIDNEY-DISEASE, Guideline, medicine.disease, glycemia, 030104 developmental biology, dialysis, glycemic monitoring, angiotensin-convering enzyme inhibitor, metformin, business, CONSENSUS, chronic kidney disease, Kidney disease

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebf0ff572cf1e092665ac918d7abc463
https://hdl.handle.net/11370/2855a8ed-ea3b-499e-b93a-07c97dee456c

7

Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease:an update based on rapidly emerging new evidence

المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Groningen Kidney Center (GKC)

المصدر: Rossing, P, Caramori, M L, Chan, J C N, Heerspink, H J L, Hurst, C, Khunti, K, Liew, A, Michos, E D, Navaneethan, S D, Olowu, W A, Sadusky, T, Tandon, N, Tuttle, K R, Wanner, C, Wilkens, K G, Zoungas, S, Craig, J C, Tunnicliffe, D J, Tonelli, M A, Cheung, M, Earley, A & de Boer, I H 2022, ' Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease : an update based on rapidly emerging new evidence ', Kidney International, vol. 102, no. 5, pp. 990-999 . https://doi.org/10.1016/j.kint.2022.06.013
Kidney International, 102(5), 990-999. ELSEVIER SCIENCE INC